المؤلفون: Park J; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea., Song H; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea., Moon S; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea., Kim Y; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea., Cho S; Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Han K; Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea., Park CY; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. cydoctor@skku.edu., Cho SW; Division of Cardiology, Department of Internal Medicine, Inje Univeristy Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Gyeonggi-Do, Korea. drswcho@hanmail.net., Oh CM; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea. cmoh@gist.ac.kr.

المصدر: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 16; Vol. 23 (1), pp. 343. Date of Electronic Publication: 2024 Sep 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/therapeutic use , Fenofibrate*/pharmacology , Obesity*/drug therapy , Heart Failure*/drug therapy , Diabetic Cardiomyopathies*/prevention & control , Diabetic Cardiomyopathies*/etiology , Diabetic Cardiomyopathies*/drug therapy , Hypolipidemic Agents*/therapeutic use, Animals ; Male ; Republic of Korea/epidemiology ; Humans ; Mice, Inbred C57BL ; Diabetes Mellitus, Experimental/drug therapy ; Diabetes Mellitus, Experimental/complications ; PPAR alpha/agonists ; PPAR alpha/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Time Factors ; Databases, Factual ; Signal Transduction/drug effects ; Myocardium/metabolism ; Myocardium/pathology ; Female ; Hospitalization ; Middle Aged ; Aged ; Inflammation Mediators/metabolism ; Inflammation Mediators/blood ; Risk Factors ; Ventricular Function, Left/drug effects

المؤلفون: Castiglioni L; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy., Gelosa P; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy., Muluhie M; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy., Mercuriali B; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy., Rzemieniec J; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy., Gotti M; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy., Fiordaliso F; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Busca G; Azienda 'Polo Veterinario di Lodi', University of Milan, Milan, Italy., Sironi L; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy. Electronic address: luigi.sironi@unimi.it.

المصدر: European journal of pharmacology [Eur J Pharmacol] 2024 Sep 05; Vol. 978, pp. 176767. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/pharmacology , Fenofibrate*/therapeutic use , Mitochondrial Dynamics*/drug effects , Cardiomegaly*/drug therapy , Cardiomegaly*/metabolism , Cardiomegaly*/pathology , Myocytes, Cardiac*/drug effects , Myocytes, Cardiac*/metabolism , Myocytes, Cardiac*/pathology , Disease Models, Animal* , Ventricular Remodeling*/drug effects, Animals ; Male ; Rats ; Autophagy/drug effects ; Hypertension, Renovascular/drug therapy ; Hypertension, Renovascular/metabolism ; Hypertension, Renovascular/pathology ; Hypertension, Renovascular/physiopathology ; Rats, Wistar ; Blood Pressure/drug effects

المؤلفون: Ku EJ; Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Kim B; Department of Statistics and Actuarial Science, Soongsil University, Seoul, South Korea., Han K; Department of Statistics and Actuarial Science, Soongsil University, Seoul, South Korea. hkd917@naver.com., Lee SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. hwanx2@catholic.ac.kr.; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, South Korea. hwanx2@catholic.ac.kr., Kwon HS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.

المصدر: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 03; Vol. 23 (1), pp. 329. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/therapeutic use , Fenofibrate*/adverse effects , Amputation, Surgical*/adverse effects , Peripheral Arterial Disease*/diagnosis , Peripheral Arterial Disease*/epidemiology , Peripheral Arterial Disease*/surgery , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/complications , Hypolipidemic Agents*/therapeutic use , Hypolipidemic Agents*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Risk Factors ; Treatment Outcome ; Republic of Korea/epidemiology ; Retrospective Studies ; Rhabdomyolysis/diagnosis ; Rhabdomyolysis/epidemiology ; Rhabdomyolysis/chemically induced ; Databases, Factual ; Time Factors ; Acute Kidney Injury/prevention & control ; Acute Kidney Injury/epidemiology ; Acute Kidney Injury/diagnosis ; Adult ; Diabetic Angiopathies/diagnosis ; Diabetic Angiopathies/prevention & control ; Diabetic Angiopathies/epidemiology

المؤلفون: Ruby HA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., 11562, Cairo, Egypt., Sayed RH; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., 11562, Cairo, Egypt; School of Pharmacy, Newgiza University, Giza, Egypt. Electronic address: rabab.sayed@pharma.cu.edu.eg., Khattab MA; Department of Cytology and Histology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt., Sallam NA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., 11562, Cairo, Egypt., Kenway SA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., 11562, Cairo, Egypt.

المصدر: European journal of pharmacology [Eur J Pharmacol] 2024 Aug 05; Vol. 976, pp. 176667. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Nitroglycerin*/pharmacology , Nitroglycerin*/toxicity , Calcitonin Gene-Related Peptide*/metabolism , Signal Transduction*/drug effects , Migraine Disorders*/drug therapy , Migraine Disorders*/chemically induced , Migraine Disorders*/metabolism , Fenofibrate*/pharmacology , Fenofibrate*/therapeutic use , Cyclic AMP Response Element-Binding Protein*/metabolism , Protein Kinase C*/metabolism , Receptors, Purinergic P2X3*/metabolism , Nerve Growth Factor*/metabolism, Animals ; Male ; Rats ; Nitric Oxide/metabolism ; Rats, Sprague-Dawley ; Behavior, Animal/drug effects

المؤلفون: Hong S; Department of Internal Medicine, Guri Hospital, College of Medicine, Hanyang University, Seoul, Republic of Korea., Kim KS; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea., Han K; Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea., Park CY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Pyung-Dong, Jongro-Gu, (03181), Seoul, Republic of Korea. cydoctor@chol.com.

المصدر: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jul 18; Vol. 23 (1), pp. 263. Date of Electronic Publication: 2024 Jul 18.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/therapeutic use , Fenofibrate*/adverse effects , Hypolipidemic Agents*/therapeutic use , Hypolipidemic Agents*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Propensity Score* , Heart Disease Risk Factors* , Databases, Factual* , Biomarkers*/blood, Humans ; Male ; Female ; Middle Aged ; Republic of Korea/epidemiology ; Aged ; Treatment Outcome ; Risk Assessment ; Time Factors ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/mortality ; Diabetes Mellitus/blood ; Triglycerides/blood ; Myocardial Infarction/mortality ; Myocardial Infarction/epidemiology ; Myocardial Infarction/diagnosis ; Myocardial Infarction/blood ; Cause of Death ; Stroke/mortality ; Stroke/epidemiology ; Stroke/prevention & control ; Stroke/diagnosis ; Stroke/blood ; Retrospective Studies ; Protective Factors ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/blood

المؤلفون: Tu B; Saint Joseph's University, 600 S 43rd Street, Philadelphia, PA 19104, USA. Electronic address: btu@sju.edu., Jonnalagadda S; Saint Joseph's University, 600 S 43rd Street, Philadelphia, PA 19104, USA. Electronic address: sjonnalagadda@sju.edu.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Sep 30; Vol. 663, pp. 124555. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Silicon Dioxide*/chemistry , Ibuprofen*/chemistry , Fenofibrate*/chemistry , Calorimetry, Differential Scanning* , Drug Carriers*/chemistry , X-Ray Diffraction*/methods , Budesonide*/chemistry , Budesonide*/administration & dosage, Porosity ; Drug Stability ; Crystallization ; Molecular Weight

المؤلفون: Wang M; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Laboratory of Antiallergic Functional Molecules, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China. hanbingnan@zstu.edu.cn., Deng Y; Department of Clinical Pharmacology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, Zhejiang 311202, China., Huang C; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Laboratory of Antiallergic Functional Molecules, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China. hanbingnan@zstu.edu.cn., Javeed A; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Laboratory of Antiallergic Functional Molecules, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China. hanbingnan@zstu.edu.cn., Wang Y; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Laboratory of Antiallergic Functional Molecules, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China. hanbingnan@zstu.edu.cn., Han B; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Laboratory of Antiallergic Functional Molecules, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China. hanbingnan@zstu.edu.cn., Jiang G; Department of Pharmacy, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou 311200, Zhejiang, China. jguojun999@hznu.edu.cn.

المصدر: Biomaterials science [Biomater Sci] 2024 Sep 10; Vol. 12 (18), pp. 4682-4694. Date of Electronic Publication: 2024 Sep 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101593571 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-4849 (Electronic) Linking ISSN: 20474830 NLM ISO Abbreviation: Biomater Sci Subsets: MEDLINE

مواضيع طبية MeSH: Wound Healing*/drug effects , Chitosan*/chemistry , Chitosan*/pharmacology , Fenofibrate*/pharmacology , Fenofibrate*/chemistry , Fenofibrate*/administration & dosage , Hydrogels*/chemistry , Hydrogels*/pharmacology , Hydrogels*/administration & dosage, Animals ; Mice ; Humans ; Polyvinyl Alcohol/chemistry ; Polyvinyl Alcohol/pharmacology ; Male ; Reactive Oxygen Species/metabolism ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/chemistry ; Anti-Inflammatory Agents/administration & dosage ; Human Umbilical Vein Endothelial Cells/drug effects ; Rats

مؤلفون مشاركون: LENS Collaborative Group

المصدر: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Sep; Vol. 41 (9), pp. e15310. Date of Electronic Publication: 2024 Feb 22.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5491 (Electronic) Linking ISSN: 07423071 NLM ISO Abbreviation: Diabet Med Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Retinopathy*/epidemiology , Diabetic Retinopathy*/diagnosis , Fenofibrate*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Double-Blind Method ; Aged ; Patient Selection ; Scotland/epidemiology ; Hypolipidemic Agents/therapeutic use ; Disease Progression ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Research Design ; Adult

المؤلفون: Lee SG; Department of Stem Cell Biology, School of Medicine, Konkuk University, Gwangjin-Gu, Seoul 05029, Republic of Korea.; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Rhee J; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Seok J; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Kim J; Department of Physiology, College of Medicine, Soonchunhyang University, Cheonan 31151, Republic of Korea., Kim MW; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Song GE; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Park S; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Jeong KS; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Lee S; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Lee YH; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Jeong Y; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Kim CY; College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea., Chung HM; Department of Stem Cell Biology, School of Medicine, Konkuk University, Gwangjin-Gu, Seoul 05029, Republic of Korea.; Miraecell Bio Co. Ltd., Seoul 04795, Korea.

المصدر: Stem cells translational medicine [Stem Cells Transl Med] 2024 Aug 16; Vol. 13 (8), pp. 750-762.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101578022 Publication Model: Print Cited Medium: Internet ISSN: 2157-6580 (Electronic) Linking ISSN: 21576564 NLM ISO Abbreviation: Stem Cells Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/pharmacology , Myocytes, Cardiac*/drug effects , Myocytes, Cardiac*/metabolism , Myocytes, Cardiac*/cytology , PPAR alpha*/agonists , PPAR alpha*/metabolism , Cell Differentiation*/drug effects , Pluripotent Stem Cells*/drug effects , Pluripotent Stem Cells*/metabolism , Pluripotent Stem Cells*/cytology, Humans

المؤلفون: Yang X; Dali University - The First Affiliated Hospital - Dali, Yunnan - China., Wang G; Dali University - The First Affiliated Hospital - Dali, Yunnan - China.

المصدر: Acta cirurgica brasileira [Acta Cir Bras] 2024 Aug 05; Vol. 39, pp. e393124. Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sociedade Brasileira Para O Desenvolvimento Da Pesquisa Em Cirurgia Curso De Pos-Graduacao Em Tecnica Operatoria E Cirurgia Experimental Escola Paulista De Medicina Country of Publication: Brazil NLM ID: 9103983 Publication Model: eCollection Cited Medium: Internet ISSN: 1678-2674 (Electronic) Linking ISSN: 01028650 NLM ISO Abbreviation: Acta Cir Bras Subsets: MEDLINE

مواضيع طبية MeSH: Mice, Transgenic* , Reperfusion Injury*/genetics , Superoxide Dismutase*/genetics , Mice, Inbred C57BL* , Fenofibrate*/pharmacology , Fenofibrate*/therapeutic use , Disease Models, Animal*, Animals ; Brain Ischemia/genetics ; Humans ; Male ; Mice ; Infarction, Middle Cerebral Artery/genetics ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use